These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36480651)

  • 1. Update on treatments for anxiety-related disorders.
    Lee HJ; Stein MB
    Curr Opin Psychiatry; 2023 Mar; 36(2):140-145. PubMed ID: 36480651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for generalized anxiety disorder.
    Byrne GJ
    Curr Opin Psychiatry; 2023 Mar; 36(2):134-139. PubMed ID: 36705012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines.
    Buszewicz M; Cape J; Serfaty M; Shafran R; Kabir T; Tyrer P; Clarke CS; Nazareth I
    Health Technol Assess; 2017 Aug; 21(45):1-138. PubMed ID: 28853392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Pharmacotherapy for Pediatric Anxiety Disorders.
    Nicotra CM; Strawn JR
    Child Adolesc Psychiatr Clin N Am; 2023 Jul; 32(3):573-587. PubMed ID: 37201968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness and Safety of Cognitive Behavioral Therapy and Pharmacotherapy for Childhood Anxiety Disorders: A Systematic Review and Meta-analysis.
    Wang Z; Whiteside SPH; Sim L; Farah W; Morrow AS; Alsawas M; Barrionuevo P; Tello M; Asi N; Beuschel B; Daraz L; Almasri J; Zaiem F; Larrea-Mantilla L; Ponce OJ; LeBlanc A; Prokop LJ; Murad MH
    JAMA Pediatr; 2017 Nov; 171(11):1049-1056. PubMed ID: 28859190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and Novel Psychopharmacological Drugs for Anxiety Disorders.
    Bandelow B
    Adv Exp Med Biol; 2020; 1191():347-365. PubMed ID: 32002937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive Behavioral Therapy, Mindfulness-Based Cognitive Therapy and Acceptance Commitment Therapy for Anxiety Disorders: Integrating Traditional with Digital Treatment Approaches.
    Apolinário-Hagen J; Drüge M; Fritsche L
    Adv Exp Med Biol; 2020; 1191():291-329. PubMed ID: 32002935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review.
    Gomez AF; Barthel AL; Hofmann SG
    Expert Opin Pharmacother; 2018 Jun; 19(8):883-894. PubMed ID: 29806492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WCA recommendations for the long-term treatment of generalized anxiety disorder.
    Allgulander C; Bandelow B; Hollander E; Montgomery SA; Nutt DJ; Okasha A; Pollack MH; Stein DJ; Swinson RP;
    CNS Spectr; 2003 Aug; 8(8 Suppl 1):53-61. PubMed ID: 14767398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment for generalized anxiety disorder in adults: an update.
    Reinhold JA; Rickels K
    Expert Opin Pharmacother; 2015; 16(11):1669-81. PubMed ID: 26159446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review.
    Strawn JR; Geracioti L; Rajdev N; Clemenza K; Levine A
    Expert Opin Pharmacother; 2018 Jul; 19(10):1057-1070. PubMed ID: 30056792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurostimulation in Anxiety Disorders, Post-traumatic Stress Disorder, and Obsessive-Compulsive Disorder.
    Freire RC; Cabrera-Abreu C; Milev R
    Adv Exp Med Biol; 2020; 1191():331-346. PubMed ID: 32002936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
    Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
    Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiety Disorders: A Review.
    Szuhany KL; Simon NM
    JAMA; 2022 Dec; 328(24):2431-2445. PubMed ID: 36573969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis.
    Strawn JR; Mills JA; Sauley BA; Welge JA
    J Am Acad Child Adolesc Psychiatry; 2018 Apr; 57(4):235-244.e2. PubMed ID: 29588049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selecting pharmacotherapy for generalized anxiety disorder.
    Goodman WK
    J Clin Psychiatry; 2004; 65 Suppl 13():8-13. PubMed ID: 15384931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine.
    Stein DJ
    Adv Ther; 2021 Sep; 38(Suppl 2):52-60. PubMed ID: 34417992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal Generalized Anxiety Disorder: Assessment and Treatment.
    Misri S; Abizadeh J; Sanders S; Swift E
    J Womens Health (Larchmt); 2015 Sep; 24(9):762-70. PubMed ID: 26125602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategies for social anxiety disorder: where are we now?
    Pelissolo A; Abou Kassm S; Delhay L
    Expert Rev Neurother; 2019 Dec; 19(12):1179-1189. PubMed ID: 31502896
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.